首页> 外国专利> FULLY HUMANIZED ANTI-PLATELET FACTOR 4 ANTIBODIES THAT TREAT HEPARIN-INDUCED THROMBOCYTOPENIA

FULLY HUMANIZED ANTI-PLATELET FACTOR 4 ANTIBODIES THAT TREAT HEPARIN-INDUCED THROMBOCYTOPENIA

机译:完全人源化抗血小板因子4抗体,可治疗肝素诱导的血小板减少症

摘要

Provided herein are isolated antibodies or antibody fragments thereof that immunospecifically bind to platelet factor 4 (PF4). In some embodiments the isolated antibodies or antigen-binding fragments thereof comprise a light chain CDR and framework region comprising SEQ ID NO: 4 and a heavy chain CDR and framework region comprising SEQ ID NO: 10. Also provided herein are methods for treating heparin-induced thrombocytopenia (HIT) and methods for reducing the likelihood that subject will become afflicted with HIT. Further disclosed are uses of the isolated antibodies or antibody fragments in the treatment of HIT or the manufacture of compositions for the treatment of HIT.
机译:本文提供了免疫特异性结合血小板因子4(PF4)的分离的抗体或其抗体片段。在一些实施方案中,分离的抗体或其抗原结合片段包含轻链CDR和包含SEQ ID NO:4的框架区以及重链CDR和包含SEQ ID NO:10的框架区。本文还提供了治疗肝素-A的方法。诱导的血小板减少症(HIT)和降低受试者遭受HIT折磨的可能性的方法。还公开了分离的抗体或抗体片段在HIT的治疗或用于HIT的治疗的组合物中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号